Vanguard Group’s Signify Health, Inc. SGFY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-6,907,005
Closed -$198M 4596
2022
Q4
$198M Buy
6,907,005
+454,504
+7% +$13.1M 0.01% 1436
2022
Q3
$188M Buy
6,452,501
+758,621
+13% +$17.5M 0.01% 1419
2022
Q2
$78.6M Buy
5,693,880
+3,368,822
+145% +$47.4M ﹤0.01% 1960
2022
Q1
$42.2M Buy
2,325,058
+29,828
+1% +$428K ﹤0.01% 2389
2021
Q4
$32.6M Buy
2,295,230
+696,324
+44% +$10.8M ﹤0.01% 2582
2021
Q3
$28.6M Sell
1,598,906
-552,757
-26% -$14.2M ﹤0.01% 2660
2021
Q2
$65.5M Buy
2,151,663
+47,585
+2% +$1.31M ﹤0.01% 2228
2021
Q1
$61.6M Buy
+2,104,078
New +$65.1M ﹤0.01% 2200

Other funds holding SGFY

Vanguard Group's SGFY Position: Q1 2023 in Review

Vanguard Group sold out of Signify Health, Inc. (SGFY) in Q1 2023, closing a stake of 6,907,005 shares — an estimated $198M sold.

Vanguard Group first reported a position in SGFY in Q1 2021 and held it in 8 quarters. The position peaked at $198M in Q4 2022. 5 funds tracked by Wall St. Rank hold SGFY as of Q1 2023.

  • Vanguard Group reported no remaining Signify Health, Inc. position as of Q1 2023 after selling out during the quarter.
  • Vanguard Group sold 6,907,005 Signify Health, Inc. shares in Q1 2023, an estimated $198M.
  • Vanguard Group first reported a position in Signify Health, Inc. in Q1 2021 and held it in 8 quarters.
  • Vanguard Group's Signify Health, Inc. position peaked at $198M in Q4 2022.
  • 5 funds tracked by Wall St. Rank held Signify Health, Inc. as of Q1 2023.

Based on Vanguard Group's 13F filing for Q1 2023, filed 15 May 2023.